J. David Hansen
Overview
J. David Hansen received an average of $2M in total compensation, including $352K in salary, at MabVax Therapeutics Holdings from 2013 to 2016.
2016MabVax Therapeutics HoldingsPresident, Chief Executive Officer and Chairman
2015MabVax Therapeutics HoldingsPresident, Chief Executive Officer and Chairman
2014MabVax Therapeutics HoldingsPresident, Chief Executive Officer and Chairman
2013MabVax Therapeutics HoldingsPresident, Chief Executive Officer and Chairman
Source: SEC filings on May 2, 2017, May 27, 2016, and July 27, 2015.
Related executives
We found 11 more executives who work or worked at MabVax Therapeutics Holdings.
Paul Resnick
MabVax Therapeutics Holdings
Vice President, Chief Business Officer
Paul Maffuid
MabVax Therapeutics Holdings
Vice President, Pharmaceutical Development and Operations
Gregory Hanson
MabVax Therapeutics Holdings
Chief Financial Officer
Wolfgang Scholz
MabVax Therapeutics Holdings
Vice President, Antibody Discovery
Michael Wick
MabVax Therapeutics Holdings
Chief Executive Officer
William Kaplan
MabVax Therapeutics Holdings
General Counsel
Wendy Wee
MabVax Therapeutics Holdings
Vice President, Finance and Controller
Steven Schow
MabVax Therapeutics Holdings